Abstract
Purpose
Cryptosporidium species is considered to be an important cause of significant morbidity in immunocompromised individuals. A prospective case–control study of sporadic diarrhea due to Cryptosporidium infection was conducted on children with acute lymphoblastic leukemia (ALL).
Methods
Forty children with ALL on maintenance chemotherapy according to the Berlin–Frankfurt–Munster (BFM-90) protocol and 45 sex- and age-matched controls were studied. The ALL group included 25 patients with acute diarrhea and 15 without diarrhea, and the control group included 30 children with acute diarrhea and 15 without. Collected stool specimens were examined using modified Ziehl–Neelsen (MZN) and modified trichrome stains. Serum Cryptosporidium Parvum immunoglobulin G (IgG) antibodies were detected by enzyme-linked immunosorbent assay.
Results
Cryptosporidium oocysts, pathogenic Gram-negative organisms, Giardia lamblia, and Entamoeba histolytica were identified in the stool samples (fecal specimens) of six (24%), eight (32%), four (16%), and two (8%), respectively, of the 25 patients with ALL and actute diarrhea and in one (3%), two (6.5%), six (20%), and five (16.5%), respectively, of the 30 control patients with diarrhea. Serum IgG antibodies were positive in four of the six ALL patients and in one of the control group patients with Cryptosporidium diarrhea who tested positive for oocysts in the stool. Diarrhea duration and severity were greater in ALL patients with stool-positive Cryptosporidium oocysts than in those with non-Cryptosporidium-positive diarrhea (p < 0.000).
Conclusions
Cryptosporidium infection should be considered in children with ALL presenting with prolonged or severe watery diarrhea during chemotherapy, especially those treated with methotrexate and 6-mercaptopurine. Since Cryptosporidium is not routinely tested for in stool examination, a MZN stain is recommended.
Similar content being viewed by others
References
Schrappe M. Evolution of BFM trials for childhood ALL. Ann Hematol. 2004;83[Suppl 1]:S121–3. doi:10.1007/s00277-004-0850-2.
Moe PJ, Holen A. High-dose methotrexate in childhood all. Pediatr Hematol Oncol. 2000;17(8):615–22. doi:10.1080/08880010050211321.
Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008;371(9617):1030–43. doi:10.1016/S0140-6736(08)60457-2.
Hunger SP, Winick NJ, Sather HN, Carroll WL. Therapy of low-risk subsets of childhood acute lymphoblastic leukemia: when do we say enough? Pediatr Blood Cancer. 2005;45(7):876–80. doi:10.1002/pbc.20501.
Bhatti A, Bansal D, Vashishta RK, Lal SB. Isolated gut relapse presenting as chronic diarrhea during maintenance therapy for acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2010;32(6):504–5. doi:10.1097/MPH.0b013e3181e0159a.
Cherny NI. Evaluation and management of treatment-related diarrhea in patients with advanced cancer: a review. J Pain Symptom Manage. 2008;36(4):413–23. doi:10.1016/j.jpainsymman.2007.10.007.
Rizzatti M, Brandalise SR, de Azevedo AC, Pinheiro VR, Aguiar Sdos S. Neutropenic enterocolitis in children and young adults with cancer: prognostic value of clinical and image findings. Pediatr Hematol Oncol. 2010;27(6):462–70. doi:10.3109/08880018.2010.489934.
Rotterdam H, Tsang P. Gastrointestinal disease in the immunocompromised patient. Hum Pathol. 1994;25(11):1123–40.
Dillingham RA, Lima AA, Guerrant RL. Cryptosporidiosis: epidemiology and impact. Microbes Infect. 2002;4(10):1059–66.
Idris NS, Dwipoerwantoro PG, Kurniawan A, Said M. Intestinal parasitic infection of immunocompromised children with diarrhoea: clinical profile and therapeutic response. J Infect Dev Ctries. 2010;4(5):309–17.
Fayer R, Morgan U, Upton SJ. Epidemiology of Cryptosporidium: transmission, detection and identification. Int J Parasitol. 2000;30(12–13):1305–22.
Bajszar G, Dekonenko A. Stress-induced Hsp70 gene expression and inactivation of Cryptosporidium parvum oocysts by chlorine-based oxidants. Appl Environ Microbiol. 2010;76(6):1732–9. doi:10.1128/AEM.02353-09.
DuPont HL, Chappell CL, Sterling CR, Okhuysen PC, Rose JB, Jakubowski W. The infectivity of Cryptosporidium parvum in healthy volunteers. N Engl J Med. 1995;332(13):855–9. doi:10.1056/NEJM199503303321304.
Schrappe M, Reiter A, Ludwig WD, Harbott J, Zimmermann M, Hiddemann W, et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90 German-Austrian-Swiss ALL-BFM Study Group. Blood. 2000;95(11):3310–22.
Chessbrought M. Medical laboratory manual for tropical countries, 2nd ed. Cambridge: ELBS. Tropical Health Technology and Butterworths; 1987.
Henriksen SA, Pohlenz JF. Staining of cryptosporidia by a modified Ziehl–Neelsen technique. Acta Vet Scand. 1981;22(3–4):594–6.
Ryan NJ, Sutherland G, Coughlan K, Globan M, Doultree J, Marshall J, et al. A new trichrome-blue stain for detection of microsporidial species in urine, stool, and nasopharyngeal specimens. J Clin Microbiol. 1993;31(12):3264–9.
Baron EJ. Rapid identification of bacteria and yeast: summary of a National Committee for Clinical Laboratory Standards proposed guideline. Clin Infect Dis. 2001;33(2):220–5. doi:10.1086/321816.
Osman GA, Makled KM, El-Shakankiry HM, Metwali DM, Abdel-Aziz SS, Saafan HH. Coccidian parasites as a cause of watery diarrhoea among protein energy malnourished and other immunocompromised Egyptian children. J Egypt Soc Parasitol. 1999;29(3):653–68.
Martin-Ampudia M, Mariscal A, Lopez-Gigosos RM, Mora L, Fernandez-Crehuet J. Under-notification of cryptosporidiosis by routine clinical and laboratory practices among non-hospitalised children with acute diarrhoea in Southern Spain. Infection. doi:10.1007/s15010-011-0188-3.
Hunter PR, Nichols G. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev. 2002;15(1):145–54.
Hassan SI, Sabry H, Amer NM, Shalaby MA, Mohamed NA, Gaballah H. Incidence of cryptosporidiosis in immunodeficient cancer patients in Egypt. J Egypt Soc Parasitol. 2002;32(1):33–46.
Kaushik K, Khurana S, Wanchu A, Malla N. Evaluation of staining techniques, antigen detection and nested PCR for the diagnosis of cryptosporidiosis in HIV seropositive and seronegative patients. Acta Trop. 2008;107(1):1–7. doi:10.1016/j.actatropica.2008.02.007.
Gwavava NJ, Pinkerton CR, Glasgow JF, Sloan JM, Bridges JM. Small bowel enterocyte abnormalities caused by methotrexate treatment in acute lymphoblastic leukaemia of childhood. J Clin Pathol. 1981;34(7):790–5.
Relling MV, Fairclough D, Ayers D, Crom WR, Rodman JH, Pui CH, et al. Patient characteristics associated with high-risk methotrexate concentrations and toxicity. J Clin Oncol. 1994;12(8):1667–72.
Lennard L, Lewis IJ, Michelagnoli M, Lilleyman JS. Thiopurine methyltransferase deficiency in childhood lymphoblastic leukaemia: 6-mercaptopurine dosage strategies. Med Pediatr Oncol. 1997;29(4):252–5. doi:10.1002/(SICI)1096-911X(199710)29:4<252:AID-MPO3>3.0.CO;2-L.
Widemann BC, Balis FM, Murphy RF, Sorensen JM, Montello MJ, O’Brien M, et al. Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction. J Clin Oncol. 1997;15(5):2125–34.
Kaushik K, Khurana S, Wanchu A, Malla N. Serum immunoglobulin G, M and A response to Cryptosporidium parvum in Cryptosporidium-HIV co-infected patients. BMC Infect Dis. 2009;9:179. doi:10.1186/1471-2334-9-179.
Trad O, Jumaa P, Uduman S, Nawaz A. Eradication of Cryptosporidium in four children with acute lymphoblastic leukemia. J Trop Pediatr. 2003;49(2):128–30.
Acknowledgments
The authors thank all of the patients who participated in our study. We are grateful to Professor El-Rifai, Wael, Professor of Surgery and Cancer Biology, for his help in revising the manuscript.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hassanein, S.M.A., Abd-El-Latif, M.M.S., Hassanin, O.M. et al. Cryptosporidium gastroenteritis in Egyptian children with acute lymphoblastic leukemia: magnitude of the problem. Infection 40, 279–284 (2012). https://doi.org/10.1007/s15010-011-0230-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-011-0230-5